Literature DB >> 16890403

Endocrine and cytokine responses in humans with pulmonary tuberculosis.

Adriana Del Rey1, Carolina V Mahuad, Verónica V Bozza, Cristina Bogue, Miguel A Farroni, María Luisa Bay, Oscar A Bottasso, Hugo O Besedovsky.   

Abstract

Endocrine responses during chronic infections such as lung tuberculosis are poorly characterized. Hormonal changes are likely to occur since some of the cytokines produced during this disease could affect endocrine mechanisms that, in turn, influence the course of infectious/inflammatory processes. A main purpose of this work was to study endocrine responses involving pituitary, adrenal, gonadal, and thyroid hormones in parallel to IFN-gamma, IL-10, and IL-6 levels in tuberculosis patients with different degree of pulmonary involvement. We have also studied whether products derived from peripheral immune cells obtained from the patients can affect the in vitro production of adrenal steroids. The population studied comprised HIV-negative newly diagnosed, untreated male patients with mild, moderate, and advanced lung tuberculosis, and matched, healthy controls. IFN-gamma, IL-10, and IL-6 levels were elevated in patients with tuberculosis. Dehydroepiandrosterone and testosterone levels were profoundly decreased and growth hormone levels were markedly elevated in patients, in parallel to modest increases in cortisol, estradiol, prolactin, and thyroid hormone concentrations. Supernatants of peripheral blood mononuclear cells obtained from the patients and stimulated in vitro with Mycobacterium tuberculosis antigens significantly inhibited dehydroepiandrosterone secretion by the human adrenal cell line NCI-H295-R. These results support the hypothesis that at least some of the endocrine changes observed in the patients may be mediated by endogenous cytokines. The endocrine profile of tuberculosis patients would favor a reduction of protective cell-mediated immunity and an exacerbation of inflammation leading to perpetuation of the lung injury and to the hypercatabolic condition that characterizes this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890403     DOI: 10.1016/j.bbi.2006.06.005

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  31 in total

Review 1.  Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.

Authors:  Matthew J Magee; Argita D Salindri; Nang Thu Thu Kyaw; Sara C Auld; J Sonya Haw; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2018-08-09       Impact factor: 4.810

2.  The impact of IFN-γ receptor on SLPI expression in active tuberculosis: association with disease severity.

Authors:  Nancy L Tateosian; Virginia Pasquinelli; Rodrigo E Hernández Del Pino; Nella Ambrosi; Diego Guerrieri; Sigifredo Pedraza-Sánchez; Natalia Santucci; Luciano D'Attilio; Joaquín Pellegrini; María A Araujo-Solis; Rosa M Musella; Domingo J Palmero; Rogelio Hernandez-Pando; Verónica E Garcia; H Eduardo Chuluyan
Journal:  Am J Pathol       Date:  2014-03-04       Impact factor: 4.307

Review 3.  Immunological roulette: Luck or something more? Considering the connections between host and environment in TB.

Authors:  John E Pearl; Mrinal Das; Andrea M Cooper
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 4.  A closed literature-based discovery technique finds a mechanistic link between hypogonadism and diminished sleep quality in aging men.

Authors:  Christopher M Miller; Thomas C Rindflesch; Marcelo Fiszman; Dimitar Hristovski; Dongwook Shin; Graciela Rosemblat; Han Zhang; Kingman P Strohl
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

Review 5.  Exploring immunomodulation by endocrine changes in Lady Windermere syndrome.

Authors:  M R Holt; J J Miles; W J Inder; R M Thomson
Journal:  Clin Exp Immunol       Date:  2019-02-27       Impact factor: 4.330

6.  IL-6 mediates 11βHSD type 2 to effect progression of the mycobacterial cord factor trehalose 6,6'-dimycolate-induced granulomatous response.

Authors:  April N Abbott; Kerry J Welsh; Shen-An Hwang; Paulina Płoszaj; Tina Choudhury; Sydney Boyd; Michael R Blackburn; Robert L Hunter; Jeffrey K Actor
Journal:  Neuroimmunomodulation       Date:  2011-03-08       Impact factor: 2.492

7.  Mycobacterium bovis DNA detection in colostrum as a potential indicator of vaccination effectiveness against bovine tuberculosis.

Authors:  Sara E Herrera-Rodríguez; María Alejandra Gordiano-Hidalgo; Gonzálo López-Rincón; Luis Bojorquez-Narváez; Francisco Javier Padilla-Ramírez; Ana Laura Pereira-Suárez; Mario Alberto Flores-Valdez; Ciro Estrada-Chávez
Journal:  Clin Vaccine Immunol       Date:  2013-02-20

8.  Characterization of human cellular immune responses to novel Mycobacterium tuberculosis antigens encoded by genomic regions absent in Mycobacterium bovis BCG.

Authors:  R Al-Attiyah; A S Mustafa
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

9.  [Association of non-thyroidal illness syndrome with interleukin-6 and interleukin-10 in critically ill children with sepsis].

Authors:  Mei-Xian Xu; Gang Liu; Li-Jing Cao; Xin-Feng Bai; Lei Kang; Xin Zhao; Xiao-Na Shi; Li-Jing Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-11

10.  Allergic sensitisation in tuberculosis patients at the time of diagnosis and following chemotherapy.

Authors:  Linda K Ellertsen; Dag G Storla; Lien M Diep; Karl A Brokstad; Harald G Wiker; Geir Hetland
Journal:  BMC Infect Dis       Date:  2009-06-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.